Program

As of 11 January 2016

20th January 2016

Post Graduate Course

Theme:  Turning points of care in liver diseases

Wednesday, 20 January 2016
9.00-10.15 Viral hepatitis
Moderators: Tawesak Tanwandee, Satawat Thongsawat
9.00-9.25 Current and future management of CHB
Seng Gee Lim, Singapore
9.25-9.50 Today treatment of CHC – which drug and how?
Teerha Piratvisuth, Thailand
9.50-10.15 Liver transplant for HCV
K.Rajender Reddy, USA
10.15-10.30 Coffee break
10.30-12.00 Metabolic liver disorders
Moderators: Teerha Piratvisuth, Chinnavat Sutthivana
10.30-10.55 Alcoholic hepatitis: steroid, pentoxifylline or liver transplantation
Diana Alcantara-Payawal, Philippines
10.55-11.20 NASH in Asia-Pacific: what’s new?
Jacob George, Australia
11.20-11.45 Non-invasive assessment of fat and fibrosis
Vincent Wong, Hong Kong
11.45-12.00 Q&A
12.00-13.30 Lunch Symposium I
Bristol-Myers Squibb Company
“New breakthrough brings effective Hepatitis C Cure“
Moderator: Tawesak Tanwandee
Speakers: Teerha Piratvisuth, Anuchit Chutaputti
13.30-14.45 New strategy in the management of decompensate cirrhosis
Moderators: Anuchit Chuttaputti, Wattana Sukeepaisarnjaroen
13.30-13.55 Natural course and prognostic stratification of cirrhosis
Abhasnee Sobhonslidsuk, Thailand
13.55-14.20 Evidence-base management of esophageal and gastric varices
Rino Alvani Gani, Indonesia
14.20-14.45 Refractory ascites and hyponatremia
Siwaporn Chainuvati, Thailand
14.45-15.00 Coffee break
15.00-16.30 Changing trends in the management of hepatocellular carcinoma
Moderators: Pisaln Mairiang, Apinya Leerapun
15.00-15.25 How to reduce the risk of HCC?
Rosmawati Mohamed, Malaysia
15.25-15.50 Current trend in the management of HCC
Grace Wong, Hong Kong
15.50-16.15 Liver transplant for HCC
Yongyut Sirivatanauksorn, Thailand
16.15-16.30 Q&A
17.00-18.30 APLD-KASL Joint Meeting
17.00-17.15 The current status of liver disease in Korea
Moderator: Kwang-Hyub Han, Korea
Speaker:  Sang Hoon Ahn, Korea
17.15-17.30 Clinical implication of hemodynamic alterations in cirrhosis
Moderator: Kwang-Hyub Han, Korea
Speaker: Soon Koo Baik, Korea
17.30-17.45 Performance of alpha-fetoprotein deteriorates by antiviral therapy in the
surveillance for hepatitis B virus-related hepatocellular carcinoma
Moderator: Seung Kew Yoon, Korea
Speaker: Jin Wook Kim, Korea
17.45-18.00 Transient elastography into the the current prediction models of HCC
Moderator: Seung Kew Yoon, Korea
Speaker: Do Young Kim, Korea
18.00-18.30 Case-based study
Panelist:
Sang Hoon Ahn, Korea
Soon Koo Baik, Korea
Jin Wook Kim, Korea
Do Young Kim, Korea
Case presenter:
Pimsiri  Sripongpun, Thailand

21st January 2016


Theme:  New paradigms in the management of liver diseases

Thursday, 21st January 2016
8.30-9.00 Plenary I
Screening of viral hepatitis and HCC: the Why and the How?

Moderator:
Anuchit Chutaputti, Thailand
Speaker:
Ray Kim, USA
9.00-9.30 Presidential lecture
Novel Endpoints of HBV therapy in the 21stCentury

Moderators:
Seng Gee Lim, Singapore
Satawat, Thongsawat, Thailand
Speaker:
Tawesak Tanwandee, Thailand
9.30-9.50 Opening Ceremony
9.50-10.20 Chainuvati Lecture
Pharmacologic management of NASH: Towards a new paradigm
Moderator:
Tawesak Tanwandee, Thailand
Speaker:
Leon Adams, Australia
10.20-10.50 Coffee break
10.50-12.00 Symposium I
New paradigms in NAFLD:
Moderators:
Sombat Treeprasertsuk, Thailand
Jacob George, Australia
10.50-11.10 1.Diets and vitamins for NAFLD, what’s known and what’s new
Leon Adams, Australia
11.10-11.30 2.”Good Bugs and Bad Bugs… Gut microbiota in NAFLD”
Phunchai Charatcharoenwitthaya, Thailand
11.30-11.50 3.HCC in the non-cirrhotic NASH patient, who gets it and can we prevent it?
Vincent Wong, Hong Kong
11.50-12.00 Discussion
12.00-13.30 Lunch Symposium II
MSD (Thailand) Ltd.
13.30-17.30 APLD-AASLD Joint Meeting
Asian and American perspectives on the management of viral hepatitis C
13.30-14.40 Symposium II
Hepatitis C: Who to treat and with what
Moderators:
Panida Thong-u-thaisri, Thailand
Rino Alvani Gani, Indonesia
13.30-13.50 1.What AASLD-IDSA guidance says
Ray Kim, USA
13.50-14.10 2.Guidance versus real life practice in the US
K.Rajender Reddy, USA
14.10-14.30 3.ASEAN perspective
Teerha Piratvisuth, Thailand
14.30-14.40 Discussion
14.40-15.00 Coffee break
15.00-16.30 Symposium III Hepatitis C in special populations
Moderators:
Piyawat Komolmit, Thailand
President of Ho Chi Minh City Association for the Study of Liver Diseases
15.00-15.20 Modern  treatment of HCV-HIV coinfection
Chutima Pramoolsinsap, Thailand
15.20-15.40 Hepatitis C and transplantation: is it time to change our thinking?
K.Rajender Reddy, USA
15.40-16.00 HCV and  renal disease
Ray Kim, USA
16.00-16.20 Management of HCV patients with hemoglobinopathies
Lai Wei, China
16.20-16.30 Discussion
16.30-17.30 Case-based study: practical practice in the management of HCV in Asia
Moderator:
Jacob George, Australia

Panelist:
Manuel Romero-Gómez, Spain 
K.Rajender Reddy, USA
Seng Gee Lim, Singapore
Lai Wei, China
 
Case presenters:

Naichaya Chamroonkul, Thailand
Apinya Leerapun, Thailand
Watcharasak Chotiyaputta, Thailand
17.30-18.00 Welcome reception
19.00-21.00 Faculty Dinner (By invitation only)

22nd January 2016


Theme:  New paradigms in the management of liver diseases

Friday, 22nd January 2016
8.30-16.30 APLD-Italian Joint Symposium
Asian and Mediterranean perspectives in the management of HBV infection
8.30-9.10 Plenary II Hepatitis B Guidelines over the decades
Moderators:
Pisit Tangkijvanich, Thailand
Ferruccio Bonino, Italy
8.30-8.45 1.Asian perspective
Satawat Thongsawat, Thailand
8.45-9.00 2.Western perspective
Ferruccio Bonino, Italy
9.00-9.10 Discussion
9.10-10.20 Symposium IV
New paradigms in the management of HBV:

Moderators:
Teerha  Piratvisuth, Thailand
Rosmawati Mohamed, Malaysia
9.10-9.30 1. Combination & Switch Therapies
Henry LY Chan, Hong Kong
9.30-9.50 2. Long Term & Stopping role in the management of NUC Therapy
Seng Gee Lim, Singapore
9.50-10.10 3. Dashboard for personalized management of chronic HBsAg carriers and CHB
Maurizia Brunetto, Italy
10.10-10.20 Discussion
10.20-10.50 Coffee break
10.50-12.00 Meet the experts (70 min)
Hepatitis B Clinical Practice: Difficult to treat Cases

(discussion of 3-4 real cases)
Moderators:
Chutima Pramoolsinsap, Thailand
President of Hepatology Society of the Philippines

Panelist:
Tawesak Tanwandee, Thailand
Seng Gee Lim, Singapore
Henry LY Chan, Hong Kong
Maurizia Brunetto, Italy

Case presenters:
Abhasnee Sobhonslidsuk, Thailand
Soonthorn  Chonprasertsuk, Thailand
Panida Thong-u-thaisri, Thailand

12.00-13.30 Lunch Symposium III
LF Asia (Thailand) Ltd.
“Medical Management of Hepatitis C”
Moderator: Tawesak Tanwandee
Speaker: K.Rajender Reddy
13.30-15.00 Symposium V
Revisiting HCC

Moderators:
Wattana Sukeepaisarnjaroen, Thailand
Khin Maung Win, Myanmar
13.30-13.50 1.The 2016 evidence for preventing HCC and HCC recurrence
Rosmawati Mohamed, Malaysia
13.50-14.10 2.Innovations in surveillance and diagnosis of very early HCCs
Linda Brown, Thailand
14.10-14.30 3.Early HCC: resect, ablate or transplant?
Grace Wong, Hong Kong
14.30-14.50 4.New paradigms in the management of intermediate HCC
Rino Alvani Gani, Indonesia
14.50-15.00 Discussion
15.00-15.30 Coffee break
15.30-16.00 Keynote lecture II: Occult HBV Infection
Moderators:
Pongphob Intaraprasong, Thailand

Speaker:
Rosmawati Mohamed, Malaysia

16.00-16.30 Keynote lecture III:  New Therapies for HBV
Moderators:
Abhasnee Sobhonslidsuk, Thailand
Teerha Piratvisuth, Thailand

Speaker:
Massimo Levrero, Italy

16.30-17.20 NAFLD: problems beyond the liver
Moderators:
Leon Adams, Australia
Supatsri Sethasine, Thailand
16.30-16.50 1.Asian Perspectives
Sombat Treeprasertsuk, Thailand
16.50-17.10 2.Italian Perspectives
Ferruccio Bonino, Italy
17.10-17.20 Discussion
17.20-17.40 New paradigm in the management of hepatic encephalopathy 

Moderator:
M.L. Taya Kitiyakara, Thailand 

Speaker:
Manuel Romero-Gómez, Spain 

17.40-18.00 THASL Annual meeting 2016

23rd January 2016


Theme:  New paradigms in the management of liver diseases

Saturday, 23rd January 2016
8.30-10.00 Symposium VI
Pearls in the management of cirrhotic patients:

Moderators:
M.L. Taya Kitiyakara, Thailand
President of Hepatology Society of the Philippines
8.30-8.55 1.Current concepts in the management of difficult ascites
Siwaporn Chainuvati, Thailand
8.55-9.20 2.Infection in cirrhosis
Chalermrat Bunchorntavakul, Thailand 
9.20-9.45 3.Friend or foe ?: PPIs and beta-blockers in cirrhotic patients
Grace Wong, Hong Kong
9.45-10.00 Discussion
10.00-10.30 Coffee break
10.30-11.00 State of the art lecture: Acute on chronic liver failure
Moderators:
Watcharasak Chotiyaputta,Thailand
Rino Alvani Gani, Indonesia

Speaker:
Yogesh Chawla, India

11.00-11.50 Plenary III
Update in management of NASH

Moderators:
Sombat Treeprasertsuk, Thailand
Rino Alvani Gani, Indonesia
11.00-11.20 1.The management of lean NASH: No weight and no time to lose?
Jacob George, Australia
11.20-11.40 2.Refractory NASH: What can we do?
Diana Alcantara-Payawal, Philippines
11.40-11.50 Discussion
12.00-13.30 Lunch
13.30-15.00 Highlights in Hepatology
Moderators:
Tawesak Tanwandee,Thailand
Wattana Sukeepaisarnjaroen, Thailand
13.30-14.00 1.Viral hepatitis
Pisit Tangkijvanich, Thailand
14.00-14.30 2.Non-viral liver diseases
Ray Kim, USA
14.30-15.00 3.Cirrhosis and liver transplantation
Piyawat Komolmit, Thailand
15.00-15.20 Closing Ceremony